DILI
Showing 1 - 25 of 70
Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule
Recruiting
- Drug-Induced Liver Injury
- +2 more
- MT2004 Capsule
- MT2004 Capsule Placebo
-
Shanghai, Shanghai, ChinaShanghai Jiaotong University School of Medicine,Renji Hospital
Aug 25, 2023
Drug-induced Liver Injury, Gut Microbiota, Biochemical Markers Trial in Wuhan (Collect stool and blood samples from patients)
Recruiting
- Drug-induced Liver Injury
- +2 more
- Collect stool and blood samples from patients
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Jul 20, 2022
Drug-Induced Acute Liver Injury Trial in Shanghai (bicyclol, 25mg/ tablet, polyene phosphatidylcholine capsules, 228mg/
Recruiting
- Drug-Induced Acute Liver Injury
- bicyclol, 25mg/ tablet
- polyene phosphatidylcholine capsules, 228mg/ particle.
-
Shanghai, Shanghai, China
- +1 more
Aug 3, 2022
Dietary Deficiency Trial in Dili (Social and behaviour change communication, Fish aggregating device)
Recruiting
- Dietary Deficiency
- Social and behaviour change communication
- Fish aggregating device
-
Dili, Timor-LesteWorldFish Timor-Leste
Oct 12, 2021
Susceptibility Genes for APAP Induced Drug Induced LIver Injury
Recruiting
- Acetaminophen
- +3 more
- genetic polymorphism
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jul 14, 2021
Drug-induced Liver Injury,Chronic Trial in Beijing (36 Weeks Methylprednisolone, 48 weeks Methylprednisolone)
Active, not recruiting
- Drug-induced Liver Injury,Chronic
- 36 Weeks Methylprednisolone
- 48 weeks Methylprednisolone
-
Beijing, ChinaBeijing 302 hospital
Sep 3, 2021
Drug-induced Liver Injury,Chronic Trial in Beijing (Methylprednisolone, Standard Treatment)
Completed
- Drug-induced Liver Injury,Chronic
- Methylprednisolone
- Standard Treatment
-
Beijing, Beijing, ChinaBeijing 302 hospital,China
Aug 7, 2020
Drug-induced Liver Injury in China(DILI-P)
Unknown status
- Drug-induced Liver Injury
-
Shanghai, ChinaRenji hospital
Apr 26, 2020
Drug-induced Liver Injury Trial in Beijing
Recruiting
- Drug-induced Liver Injury
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Aug 27, 2022
Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)
Recruiting
- Tuberculosis
- +2 more
- N acetyl cysteine
-
Bangkok, ThailandFaculty of Medicine, Siriraj Hospital
Feb 12, 2023
Acute Liver Failure, Acute-On-Chronic Liver Failure Trial (F573 for injection, Sterilizing water for injection)
Not yet recruiting
- Acute Liver Failure
- Acute-On-Chronic Liver Failure
- F573 for injection
- Sterilizing water for injection
- (no location specified)
Jan 9, 2023
PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive
Not yet recruiting
- Autoimmune Hepatitis
- Autoimmune Liver Disease
- polyreactive immunoglobulin G
- (no location specified)
Apr 11, 2023
Drug-Induced Acute Liver Injury Trial in China (bicyclol tablet 25mg, bicyclol tablet 50mg, polyene phosphatidylcholine capsule
Completed
- Drug-Induced Acute Liver Injury
- bicyclol tablet 25mg
- +2 more
-
Hefei, Anhui, China
- +16 more
Apr 26, 2020
Soft Tissue Sarcoma Trial in Santa Monica (L19TNF, DOXORUBICIN)
Active, not recruiting
- Soft Tissue Sarcoma
-
Santa Monica, CaliforniaSarcoma Oncology Research Center (SORC) Cancer Center of Souther
Apr 19, 2022
The Markers and Paracetamol Poisoning Study 2
Recruiting
- Paracetamol Overdose
- Surplus blood tests
-
Edinburgh, United KingdomNHS Lothian
Sep 27, 2022
Checkpoint Inhibitor-induced Liver Injury
Recruiting
- Immune-Mediated Hepatitis
- Obtaining biological samples
-
Nottingham, United KingdomUniversity of Nottingham
Sep 28, 2021
Hospital-acquired Pneumonia Trial in Worldwide (Baricitinib 4 MG)
Not yet recruiting
- Hospital-acquired Pneumonia
- Baricitinib 4 MG
-
Bruxelles, Belgium
- +28 more
Jun 13, 2023
Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)
Recruiting
- Drug-Induced Acute Liver Injury
- Bicyclol tablets
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 2, 2023
Primary Biliary Cholangitis Trial in Indianapolis (Saroglitazar Magnesium 1 mg, Saroglitazar Magnesium 2 mg, Placebo)
Recruiting
- Primary Biliary Cholangitis
- Saroglitazar Magnesium 1 mg
- +2 more
-
Indianapolis, IndianaZydus site 1
Apr 28, 2022